San Francisco, CANCT04750616Now EnrollingIRB Ready

Ischemia Reperfusion Injury Clinical Trial in San Francisco, CA

Access cutting-edge ischemia reperfusion injury treatment through this phase 2 clinical trial at a research site in San Francisco. Study-provided care at no cost to qualified participants.

Sponsored by Kaiser Permanente

Quick Self-Assessment

See if you qualify for this San Francisco location

Preparing your pre-screening questions…

Expert Care in San Francisco

Access ischemia reperfusion injury specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related ischemia reperfusion injury treatment provided free

Apply for This San Francisco Location

Check if you qualify for this ischemia reperfusion injury clinical trial in San Francisco, CA

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to San Francisco

    Convenient for CA residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit San Francisco site if eligible
  4. 4Begin participation

About This Ischemia Reperfusion Injury Study in San Francisco

A Randomized, Double-blind, placebo-controlled Trial to Evaluate the Efficacy of Oral Nam for the Prevention of Acute Kidney Injury in Patients Undergoing On-Pump Cardiac Surgery

Sponsor: Kaiser Permanente

Who Can Participate

Inclusion Criteria

Informed consent before any study-related activities.
Men or women \>18 years of age who are scheduled for non-emergent cardiac surgery procedures requiring CPB and are at increased risk for surgery-related adverse cardiovascular outcomes. Procedures include:
Aortic, mitral, tricuspid, or pulmonic valve replacement or repair
CABG with aortic, mitral, tricuspid, and/or pulmonic valve replacement Risk factors for surgery related to adverse cardiovascular outcomes include one or more of the following:
Valve surgery
eGFR \< 45 ml/min/1.73m2
Documented LVEF ≤ 35% within six months before surgery
Documented history of heart failure
Insulin-requiring diabetes
Non-insulin-requiring diabetes and the presence of ≥+2 proteinuria on urinalysis (or equivalent on urine protein-to-creatinine ratio or urine albumin-to-creatinine ratio)
Preoperative anemia (hemoglobin \<11g/dl for men and women)
History of prior CABG

Exclusion Criteria

Preexisting AKI within seven days before surgery as defined by KDIGO stage ≥1 (serum creatinine-based)
Kidney transplant status
Off-pump cardiac surgery
Emergent cardiac surgery
Patient enrolled in competing research studies that may affect outcomes
Patients held in an institution by legal or official order

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in San Francisco?

Yes, this clinical trial (NCT04750616) has an active research site in San Francisco, CA that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Ischemia Reperfusion Injury Treatment Options in San Francisco, CA

If you're searching for ischemia reperfusion injury treatment options in San Francisco, CA, this clinical trial (NCT04750616) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our San Francisco research site is actively enrolling participants for this phase 2 clinical trial. You'll receive care from experienced ischemia reperfusion injury specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all ischemia reperfusion injury clinical trials near you to find additional studies recruiting in your area.

More Heart Attack Trials in San Francisco, CA

See all heart attack clinical trials recruiting in San Francisco — not just this study.

Browse Heart Attack Trials in San Francisco →

Browse More Trials by Condition

Heart Attack TrialsPulmonary Embolism TrialsMyocardial Infarction TrialsAll Conditions →

Ready to Join in San Francisco?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · San Francisco, CA